Webinar | Jan. 31st

Join Median Technologies and Labcorp’s experts to gain insight into Decentralized Clinical Trial strategies and tools to consider for your next oncology trial.

Register now

Median's latest news

We were happy to welcome a large audience during our webcast on Oct. 26th, 2022. The opportunity for Fredrik Brag, CEO and founder of Median, to share the company’s news and prospects and respond to the many questions from participants. The webcast recording is now available!

Watch video

Latest press releases

24 January 2023

Median Technologies to host two webcasts and provide a company update on February 2, 2023

Median Technologies (ALMDT:PA) announced today that Fredrik Brag, CEO and founder of Median Technologies, will provide a company update on February 2nd, 2023 during two webcasts

24 January 2023

Median Technologies fera un point d’avancement au cours de deux webcasts le 2 février 2023

Median Technologies (ALMDT:PA) annonce aujourd’hui que Fredrik Brag, Directeur Général et fondateur de Median Technologies fera un point d’avancement concernant la société, lors de deux webcasts le 2 février 2023.

19 January 2023

Median Technologies annonce un chiffre d’affaires 2022 de 23,8 m€ en hausse de 16 % et un carnet de commandes de 60,8 m€

Chiffre d’affaires de 23,8 m€ au 31 décembre 2022, une augmentation de 16 % par rapport au chiffre d’affaires 2021 (20,5 m€). Carnet de commandes à 60,8 m€ au 31 décembre 2022. Trésorerie et équivalent de trésorerie à 21,5 m€ au 31 décembre 2022

19 January 2023

Median Technologies announces 2022 revenue of €23.8 million, up 16%, and an order backlog of €60.8 million

Revenue of €23.8 million as of December 31, 2022, up 16% versus 2021 (€20.5 million). Order backlog at €60.8 million as of December 31, 2022. Cash and cash equivalents of €21.5 million as of December 31, 2022.

21 December 2022

Financial Communications Schedule for the First Half of 2023

Median Technologies (ALMDT:PA), announces the publication date for its 2022 results.

1/5

Our Winter Corporate Newsletter

We are pleased to share with you our latest Corporate Newsletter, presenting our most recent announcements. Click below to read the Newsletter!

Webinars

Januray 31st, 2023

Decentralized Clinical Trials: The patient-centric future of oncology R&D?

Join Labcorp Drug Development and Median Technologies leaders in a stimulating conversation to learn how proven, modern, decentralized clinical trial (DCT) strategies will improve patient compliance and engagement, accelerate timelines, and decrease site burden.

Full or Hybrid DCT? What is the best fit when it comes to oncology research, the role of clinical trial imaging with these models, and how do you ensure success? Join this webinar to gain insight into DCT strategies and tools to consider for your next oncology trial. If you are a sponsor, CRO, site investigator or a physician, this webinar is for you! Register now.

Imaging for clinical trials

Advancing treatments of the future

Working with biopharma companies and leading medical centers around the world, the team at Median enable researchers to identify disease fingerprints from medical images. We’re helping paving the way for new personalized and innovative medicines, more accurate and predictable diagnoses and better treatments.

Read more

iBiopsy®

Enhancing imaging diagnostic accuracy

Our team of data scientists, AI engineers and clinicians is focused on developing the most accurate and cutting-edge AI-powered Software as a Medical Device (SaMD). iBiopsy® targets: lung cancer, liver cancer, and NASH to provide to patients an earlier and optimal diagnosis avoiding unnecessary invasive tests.

Read more

Investors

Delivering value

Our technology and expertise is creating a new world of possibilities for biopharmaceutical and healthcare professionals around the world. By successfully helping improve the lives of millions, we are also delivering value for our investors and partners.

Read more

Stock Market Data

TICKER: ALMDT ISIN: FR0011049824
Get in touch

Together, let's build the future of medicine

Contact us Jobs at Median